MedPath

Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology

Completed
Conditions
Incisional Hernia
Extracellular Matrix Alteration
Interventions
Diagnostic Test: Transcriptomic analysis
Registration Number
NCT06366581
Lead Sponsor
Fudan University
Brief Summary

This study included patients who underwent surgical treatment for incisional hernia and non-hernia conditions. Surgical specimens were collected for transcriptome sequencing to obtain the gene expression list. Then genes analyzed by Gene Ontology, protein interactions, and signaling pathway enrichment using the expression matrix.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria

1.18 to 75 years 2.diagnosed with incisional hernia 3.normal tumour markers 4.elective surgery patients.

Read More
Exclusion Criteria
  1. patients with vital organ failure (heart liver, lung, kidney and others)
  2. malignant tumors not been completely relieved by active treatment,
  3. patients who have psychiatric diseases or comprehension disorders.
  4. patients with metabolic disease involving connective tissue collagen.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NC groupTranscriptomic analysispatients who underwent laparoscopic cholecystectomy were defined as the control group (labelled as the NC group)
IH groupTranscriptomic analysisPatients who underwent incisional hernia repair were defined as the experimental group (labelled as the IH group)
Primary Outcome Measures
NameTimeMethod
the gene expression list2023.3-2023.9

the gene expression list

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hua Dong Hospital Affiliated to Fu Dan University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath